Search results
Biogen (BIIB) Partner Eisai Seeks Nod for Lecanemab in Japan
Zacks via Yahoo Finance· 1 year agoBiogen Inc. BIIB and partner Eisai announced that the latter submitted a marketing authorization...
South Korea’s MFDS approves Eisai-Biogen’s LEQEMBI for Alzheimer’s
Pharmaceutical Technology via Yahoo Finance· 1 week agoThe South Korean Ministry of Food and Drug Safety (MFDS) has granted approval for Eisai and Biogen’s...
Eisai: 2024 TIME100 Most Influential Companies
Time via Yahoo Finance· 5 days agoThe Alzheimer’s drug Leqembi Credit - Eisai/Reuters By the end of 2024, Japanese pharmaceutical firm Eisai could be among the few companies with a drug...
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
Zacks via Yahoo Finance· 2 months agoPer Biogen (BIIB)/Eisai, the delay in CHMP recommendation for lecanemab is entirely related to...
The FDA just approved a new Alzheimer's drug that's set to be a blockbuster
Business Insider via Yahoo News· 1 year agoGetty Images The FDA just approved a new treatment for Alzheimer's disease from Eisai and Biogen. In...
A New Drug Could Slow Alzheimer’s Disease, Data Show
Time via Yahoo News· 2 years agoCredit - Ronnie Kaufman/Larry Hirshowitz/Blend Images LLC—Getty Images Over the past few years, Alzheimer’s patients and their caregivers have been on a...
Catalyst Pharma Acquires US Rights To Eisai's Epilepsy Drug
Benzinga via Yahoo Finance· 1 year agoCatalyst Pharmaceuticals Inc (NASDAQ: CPRX) agreed to acquire the U.S. rights to Eisai Co Ltd's...
After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
Associated Press via Yahoo News· 8 months agoJapan's health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly...
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning
Investor's Business Daily· 7 months agoThe hunt for Alzheimer's treatments marked key victories this year, with breakthroughs from Biogen,...
Catalyst (CPRX) Down on TEVA's FDA Filing for Firdapse Generic
Zacks via Yahoo Finance· 1 year agoCatalyst Pharmaceuticals (CPRX) receives a notice letter stating that Teva Pharmaceuticals has filed...
